Daiichi Sankyo | 4568 - Selling And Administration Expenses


Daiichi Sankyo reported JPY228.23B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Astellas Pharma JPY 234.7B 12.92B Mar/2026
Chugai Pharma JPY 28.9B 8.02B Mar/2026
Daiichi Sankyo JPY 228.23B 39.15B Dec/2025
Eisai JPY 119.54B 7.82B Mar/2026
Kyowa Hakko Kirin JPY 41.07B 2.82B Mar/2026
M3 JPY 26.84B 349M Mar/2026
Otsuka Holdings JPY 259.49B 18.81B Mar/2026
Shionogi JPY 38.04B 2.56B Mar/2026
Sumitomo Dainippon JPY 43.06B 2.16B Mar/2026
Takeda JPY 292B 9.21B Mar/2026
Terumo JPY 114.81B 9.55B Mar/2026